signalling thresholds negative b-cell selection acute lymphoblastic leukaemia 
b cells selected intermediate level b-cell antigen receptor bcr signalling strength: attenuation minimumfor example non-functional bcr1 hyperactivation maximum example self-reactive bcr23 thresholds signalling strength causes negative selection similar % cases acute lymphoblastic leukaemia cells carry oncogenic bcr-abl1 tyrosine kinase philadelphia chromosome positive mimics constitutively active pre-bcr signalling45 current therapeutic approaches largely focused development potent tyrosine kinase inhibitors suppress oncogenic signalling minimum threshold survival6 tested hypothesis targeted hyperactivation-above maximum threshold-will engage deletional checkpoint removal self-reactive b cells selectively kill cells find testing various components proximal pre-bcr signalling mouse bcr-abl1 cells incremental increase syk tyrosine kinase activity required sufficient induce cell death hyperactive syk functionally equivalent acute activation self-reactive bcr cells despite oncogenic transformation basic mechanism negative selection still functional cells unlike normal pre-b cells patient-derived cells express inhibitory receptors pecam1 cd300a lair1 high levels genetic studies revealed pecam1 cd300a lair1 critical calibrate oncogenic signalling strength recruitment inhibitory phosphatases ptpn6 ref inpp5d ref using novel small-molecule inhibitor inpp5d also known ship19 demonstrated pharmacological hyperactivation syk engagement negative b-cell selection represents promising new strategy overcome drug resistance human 
